The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skillsets and life experiences. CHAI is deeply grounded in the countries we work in, with majority of our staff based in program countries.
In India, CHAI works in partnership with its India registered affiliate William J Clinton Foundation (WJCF) under the guidance of the Ministry of Health and Family Welfare (MoHFW) at the Central and States' levels on an array of high priority initiatives aimed at improving health outcomes. Currently, WJCF supports government partners across projects to expand access to quality care and treatment for HIV/AIDS, Hepatitis, tuberculosis, COVID-19, common cancers, sexual and reproductive health, immunization, and essential medicines.
Learn more about our exciting work: http://www.clintonhealthaccess.org
With the objective of reducing maternal, child, and overall mortality from hypoxemia related cases, WJCF is supporting the national government and the states of Madhya Pradesh, Chhattisgarh, and Punjab in improving the supply and use of high-quality oxygen services at the health facility level to ensure that hypoxemic patients receive oxygen therapy leading to improved patient outcomes. To achieve this objective, the Essential Medicines and Oxygen (EM & O2) program focuses on the following key elements:
• Increased sustainable financing for oxygen access.
• Effective planning and strategies to manage oxygen systems.
• Affordable, efficient, and high-quality oxygen procurement and distribution systems.
• Improved clinical administration and technical management of oxygen.
• Improved data, information systems, and monitoring for oxygen access.
At the national level, WJCF is supporting the Ministry of Health and Family Welfare (MoH&FW) coordinate with the health leadership at the states level to ensure availability and access to oxygen, capacity building to ensure optimal functioning and monitoring of oxygen infrastructure, and uptake of digital systems for monitoring oxygen demand and efficient asset utilization. At the states level, WJCF is supporting the state health and facility level leadership define governance structures, ensure optimal maintenance and upkeep of oxygen assets, build capacity for efficient utilization of assets and provision of clinical care, monitoring use of and access to oxygen, and develop and leverage requisite structures and financing mechanisms to ensure sustainability. Through this support WJCF expects to ensure access to high quality medical oxygen to manage hypoxemia, including in cases high risk cases such pneumonia; maternal, neonatal, and paediatric cases; respiratory diseases, at intensive and high-dependency units and for trauma / emergency care, while ensuring adequate preparedness to manage surge of Covid-19 cases or on account of other acute or seasonal respiratory ailments.
The Senior Associate, Essential Medicines and Oxygen Access (EM & O2) will be responsible for co-developing programme strategy at the national level with the programme leadership and support the management on implementation progress of the entire portfolio across geographies in all focus states. This role entails a combination of strategy building, implementation management, team mentorship, and stakeholder engagement. Importantly, the person coming in will be entrusted with portfolio growth as a key result area. Based out of Delhi, the Senior Associate, EM & O2 will report to the Senior Manager, EM & O2.
We seek a highly qualified and motivated individual with strong analytical, quantitative, and strategy development skills and an exemplary record of leadership and management. The successful candidate will have excellent communications skills, be able to function independently with flexibility in a dynamic and ambiguous environment, be self-motivated, thrive in challenging environments, and have a strong commitment to excellence. A successful candidate will also to be adept at coordinating the operations of cross-functional and multi-location teams. We place great value on personal qualities such as: resourcefulness, responsibility, tenacity, independence, energy, and work ethic.